For instance, the prostate-specific antigen (kallikrein-3) and kallikrein 2 are representative biomarkers in prostate cancer [8], promoting prostate cancer progression through activating malignant cell proliferation invasion, and extracellular matrix (ECM) degradation [31]. This evidence concerns the gene KLK2 and prostate cancer.